← Back to Search

5S Trial for Suicide Prevention

Phase 3
Recruiting
Led By Brian Ahmedani, PhD, MSW
Research Sponsored by Henry Ford Health System
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
18 years of age or older
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 6-months from jail release date
Awards & highlights
No Placebo-Only Group
Pivotal Trial

Summary

"This trial aims to combine information from jail release records with electronic health records to help connect patients to effective suicide prevention and clinical care after they are released from jail."

Who is the study for?
This trial is for adults who have been released from jail between February 2021 and July 2028, had a primary care or behavioral health visit at a participating system in the last 3 years, and live in the same state as the study site. It's not for those who've opted out of research or need a translator.
What is being tested?
The '5S Trial' aims to sync jail release records with health records to connect individuals to suicide prevention services after they leave jail. The goal is to create a seamless clinical care pathway that addresses suicide risks.
What are the potential side effects?
Since this trial involves data management and service connection rather than medication or medical procedures, it does not have traditional side effects. However, participants may experience stress or discomfort discussing sensitive topics.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am 18 years old or older.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~6-months from jail release date
This trial's timeline: 3 weeks for screening, Varies for treatment, and 6-months from jail release date for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Composite measures of suicide attempt and death

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.
Pivotal Trial
The final step before approval, pivotal trials feature drugs that have already shown basic safety & efficacy.

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: 5S TrialExperimental Treatment1 Intervention
Participants will receive an intervention aimed at suicide prevention in this group.
Group II: No-Contact Control GroupActive Control1 Intervention
Participants will be able to engage with healthcare services as usual and will have no knowledge of their involvement in the study.

Find a Location

Who is running the clinical trial?

National Institute of Mental Health (NIMH)NIH
2,913 Previous Clinical Trials
2,678,535 Total Patients Enrolled
35 Trials studying Suicide Prevention
146,881 Patients Enrolled for Suicide Prevention
HealthPartners InstituteOTHER
192 Previous Clinical Trials
3,661,558 Total Patients Enrolled
Michigan State UniversityOTHER
198 Previous Clinical Trials
625,240 Total Patients Enrolled
2 Trials studying Suicide Prevention
920 Patients Enrolled for Suicide Prevention
~40000 spots leftby Jun 2027
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top